OR WAIT null SECS
June 19, 2019
The companies have signed a strategic multi-year manufacturing agreement for the future commercial production a late-phase investigational cell therapy.
June 13, 2019
The acquisition will boost Merck’s pipeline for cancer, fibrosis, and autoimmune disease therapeutics.
May 30, 2019
MilliporeSigma awarded its Advance Biotech Grant to three US companies that are focused on traumatic brain injury, vaccine development, and chronic pain.
May 28, 2019
The agency says Novartis drug is the first PI3K inhibitor to be approved for treating breast cancer.
May 15, 2019
The acquisition provides Valby, Denmark-based Lundbeck with a discovery platform and a US-based research hub.
May 13, 2019
The acquisition will expand Pfizer’s rare disease portfolio with an early pipeline candidate for treating dwarfism.
Harvard University researchers used single-cell sequencing to identify a protein expressed uniquely by insulin-producing beta cells created from stem cells in the laboratory.
May 10, 2019
Lonza will provide development and manufacturing services to two of Alector’s neurodegeneration drug candidates.
May 07, 2019
The companies will work together to develop observational research analytics to assess treatment outcomes for areas of unmet need in oncology.
April 29, 2019
A new facility in Frederick County, MD, will expand the company’s cell therapy manufacturing capabilities.